E-LIB Suche - Ergebnisse für: Grover, J.

1

Lipid-Lowering Therapy Utilisation and LDL-C Goal Achieveme..:

Nawaz, S. ; Leung, A. ; Yao, W....
Heart, Lung and Circulation. 33 (2024) - p. S525 , 2024

Link: https://doi.org/10.1016/..

2

Sodium-Glucose Cotransporter 2 Inhibitors Confer Favourable..:

Theertham, A. ; Leung, A. ; Upadhyay, J....
Heart, Lung and Circulation. 33 (2024) - p. S537 , 2024

Link: https://doi.org/10.1016/..

3

Characterising Risk Factors and Lipid Profiles in Obese Pat..:

Grover, J. ; Yao, W. ; Leung, A....
Heart, Lung and Circulation. 33 (2024) - p. S514 , 2024

Link: https://doi.org/10.1016/..

4

In-Hospital Identification of Patients Who Would Benefit Fr..:

Upadhyay, J. ; Leung, A. ; Thondup, T....
Heart, Lung and Circulation. 33 (2024) - p. S522 , 2024

Link: https://doi.org/10.1016/..

5

Characterising Differences in Lipid Profiles and Disease Se..:

Grover, J. ; Leung, A. ; Yao, W....
Heart, Lung and Circulation. 33 (2024) - p. S513-S514 , 2024

Link: https://doi.org/10.1016/..

6

Coronary Artery Disease and Chronic Kidney Disease—What Rol..:

Leung, A. ; Theertham, A. ; Upadhyay, J....
Heart, Lung and Circulation. 33 (2024) - p. S516 , 2024

Link: https://doi.org/10.1016/..

7

In-Hospital Characterisation of Lipid Profiles and Therapy ..:

Upadhyay, J. ; Leung, A. ; Theertham, A....
Heart, Lung and Circulation. 33 (2024) - p. S465-S466 , 2024

Link: https://doi.org/10.1016/..

8

Lipid Profiles, Severity of Coronary Artery Disease and Cli..:

Nawaz, S. ; Leung, A. ; Yao, W....
Heart, Lung and Circulation. 33 (2024) - p. S524 , 2024

Link: https://doi.org/10.1016/..

9

Efficacy of the Different Statins and Combination Therapies..:

Thondup, T. ; Upadhyay, J. ; Leung, A....
Heart, Lung and Circulation. 33 (2024) - p. S517-S518 , 2024

Link: https://doi.org/10.1016/..

10

Dark matter reconstruction from stellar orbits in the Galac..:

Lechien, T. ; Heißel, G. ; Grover, J..
Astronomy & Astrophysics. 686 (2024) - p. A179 , 2024

Link: https://doi.org/10.1051/..

11

Efficacy of PCSK9 Inhibitors in the Prevention of Cardiovas..:

Grover, J. ; Yao, W. ; Amarasekera, A....
Heart, Lung and Circulation. 33 (2024) - p. S517 , 2024

Link: https://doi.org/10.1016/..

12

Lower Levels of High-Density Lipoprotein Cholesterol are As..:

Yao, W. ; Grover, J. ; Nawaz, S....
Heart, Lung and Circulation. 33 (2024) - p. S526 , 2024

Link: https://doi.org/10.1016/..

13

Are Overseas-born Patients at Higher Risk of Cardiovascular..:

Nawaz, S. ; Leung, A. ; Yao, W....
Heart, Lung and Circulation. 32 (2023) - p. S383 , 2023

Link: https://doi.org/10.1016/..

14

Predictors of Successful Weaning From Veno-Arterial Extraco..:

Grover, J. ; Sekhar, P. ; Hsu, H...
Heart, Lung and Circulation. 32 (2023) - p. S301-S302 , 2023

Link: https://doi.org/10.1016/..

15

In-hospital Assessment of Cardiovascular Risk Factors: A Mi..:

Yao, W. ; Leung, A. ; Grover, J....
Heart, Lung and Circulation. 32 (2023) - p. S390 , 2023

Link: https://doi.org/10.1016/..